Xenleta: payments to doctors
Payments that named Xenleta as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $125K
- Providers
- 2,639
- Transactions
- 3,745
- Average per transaction
- $33
The per-transaction average — $33 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,639 providers the average total is $48, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Nabriva Therapeutics, PLC | $125,417 | 100.0% |